Daiwa Securities Group
TNGX icon

Daiwa Securities Group’s Tango Therapeutics TNGX Stock Holding History

Daiwa Securities Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-355
Closed -$3K – 1426
2025
Q4 		$3K Hold
355
– – ﹤0.01% 1287
2025
Q3 		$3K Hold
355
– – ﹤0.01% 1252
2025
Q2 		$2K Hold
355
– – ﹤0.01% 1230
2025
Q1 		$0 Hold
355
– – ﹤0.01% 1318
2024
Q4 		$1K Hold
355
– – ﹤0.01% 1270
2024
Q3 		$3K Hold
355
– – ﹤0.01% 1206
2024
Q2 		$3K Hold
355
– – ﹤0.01% 1238
2024
Q1 		$3K Hold
355
– – ﹤0.01% 1250
2023
Q4 		$4K Hold
355
– – ﹤0.01% 1233
2023
Q3 		$4K Hold
355
– – ﹤0.01% 1180
2023
Q2 		$1K Hold
355
– – ﹤0.01% 1301
2023
Q1 		$1K Hold
355
– – ﹤0.01% 1284
2022
Q4 		$3K Buy
+355
New +$2.5K ﹤0.01% 1207

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Daiwa Securities Group's TNGX Position: Q1 2026 in Review

Daiwa Securities Group sold out of Tango Therapeutics (TNGX) in Q1 2026, closing a stake of 355 shares — an estimated $3K sold.

Daiwa Securities Group first reported a position in TNGX in Q4 2022 and held it in 13 quarters. The position peaked at $4K in Q4 2023. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Daiwa Securities Group reported no remaining Tango Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 355 Tango Therapeutics shares in Q1 2026, an estimated $3K.
  • Daiwa Securities Group first reported a position in Tango Therapeutics in Q4 2022 and held it in 13 quarters.
  • Daiwa Securities Group's Tango Therapeutics position peaked at $4K in Q4 2023.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.